DEBORAH GRIFFIN: Open Payments
NPI 1265430490 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 67 payments from 19 companies in 2025. Trend: 2023 $1,096 · 2024 $1,850 · 2025 $1,538
Food & beverage: $1,538
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $250 |
| Amgen Inc. | 11 | $231 |
| Edwards Lifesciences Corporation | 1 | $138 |
| PFIZER INC. | 6 | $119 |
| Merck Sharp & Dohme LLC | 4 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| Itamar Medical Inc | 1 | $72 |
| CVRx, Inc. | 3 | $60 |
Products named: LEQVIO, REPATHA, VYNDAQEL, Kerendia, JARDIANCE, CAMZYOS, WatchPATONE, VERQUVO.
Industry payments across CO — which companies pay providers there.
